Stone-free Rates

The reported proportion depends partly on when clinicians perform follow-up imaging and how they define an acceptable residual burden. An assessment made at one time point may not match a later evaluation, while a threshold that permits clinically significant fragments can classify patients differently from one requiring no detectable stones. These criteria should therefore accompany any reported rate.

These categories represent different clinical interpretations of treatment outcome. A patient may have a small residual fragment that does not meet the study’s threshold for clinically significant stone burden, even though imaging does not show complete absence of material. Stating the residual-fragment threshold makes the result clearer and helps readers understand what the reported outcome actually includes.

They provide a shared outcome measure for evaluating these procedures in patients with kidney or ureteral stones. However, comparisons are most meaningful when the studies use clearly defined imaging methods, assessment times, and residual-fragment thresholds. The rate then describes procedural effectiveness within those criteria rather than serving as an isolated summary of overall patient benefit.

Clinicians assess the outcome with follow-up computed tomography, ultrasound, or plain radiography. The selected imaging method records whether stones or residual fragments remain at the specified assessment time, using the study’s stated threshold. Because the reported result is based on follow-up imaging, the modality and timing should be documented when interpreting or comparing findings.

A high rate does not by itself describe the complete treatment experience. Clinicians and researchers interpret it together with complications, the need for retreatment, and patient symptoms. This broader view helps distinguish procedural effectiveness from other clinically important outcomes and supports more balanced decisions when selecting an approach for urinary stones.

The measure helps clinicians evaluate how effectively different procedures clear kidney or ureteral stones, including ureteroscopy, shock wave lithotripsy, and percutaneous nephrolithotomy. When combined with symptoms, complications, and retreatment requirements, it contributes to treatment selection rather than determining the choice alone. Its value is greatest when the assessment criteria are explicitly defined.

Researchers use the measure to evaluate procedural effectiveness and compare approaches for urolithiasis. Reporting the imaging method, assessment time, and residual-burden threshold provides context for interpreting results across studies. Pairing the rate with complications, retreatment needs, and symptoms also supports research aimed at improving the overall quality of stone-treatment care.